Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Infectious Disease - Page 49

Infectious Disease

Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Influenza | Therapeutics

Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients

On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…

Read More Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patientsContinue

Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
Biotechnology | COVID-19 | Infectious Disease | Medical Device | Therapeutics

Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery

On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….

Read More Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated deliveryContinue

Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
COVID-19 | Infectious Disease | Therapeutics

Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates

On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…

Read More Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidatesContinue

Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA
Biotechnology | Diagnostics | Infectious Disease | Influenza | Medical Device

Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA

On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…

Read More Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDAContinue

Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine

On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…

Read More Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccineContinue

Medtronic launched new solutions to help monitor patients for COVID-19
Biotechnology | COVID-19 | Infectious Disease | Medical Device

Medtronic launched new solutions to help monitor patients for COVID-19

On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…

Read More Medtronic launched new solutions to help monitor patients for COVID-19Continue

Emory University new site in NIH-sponsored coronavirus vaccine study
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine

Emory University new site in NIH-sponsored coronavirus vaccine study

On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…

Read More Emory University new site in NIH-sponsored coronavirus vaccine studyContinue

Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
Chemical | COVID-19 | Infectious Disease | Medicine | Pharmaceutical | Therapeutics

Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas

On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…

Read More Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of TexasContinue

iBio announced advancement of COVID-19 vaccine program
COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

iBio announced advancement of COVID-19 vaccine program

On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…

Read More iBio announced advancement of COVID-19 vaccine programContinue

iBio supporting AzarGen Biotechnologies’ development of a Rituximab biosimilar at  Bryan, Texas facility
COVID-19 | Infectious Disease | Medicine | Therapeutics

iBio supporting AzarGen Biotechnologies’ development of a Rituximab biosimilar at Bryan, Texas facility

On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed…

Read More iBio supporting AzarGen Biotechnologies’ development of a Rituximab biosimilar at Bryan, Texas facilityContinue

The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine

The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research

On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…

Read More The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 researchContinue

Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
Biotechnology | Infectious Disease | Influenza | Therapeutics | Vaccine

Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial

On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…

Read More Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trialContinue

Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research

Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19

On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…

Read More Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19Continue

$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care

On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…

Read More $1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary careContinue

serum therapy used as possible COVID-19 treatment
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine

serum therapy used as possible COVID-19 treatment

On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…

Read More serum therapy used as possible COVID-19 treatmentContinue

CSL Group to help battle Coronavirus
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

CSL Group to help battle Coronavirus

On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…

Read More CSL Group to help battle CoronavirusContinue

Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients

On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…

Read More Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patientsContinue

Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…

Read More Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic responseContinue

Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs

On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…

Read More Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needsContinue

Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…

Read More Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumoniaContinue

Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide

On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…

Read More Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwideContinue

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…

Read More Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task ForceContinue

Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
Biotechnology | Infectious Disease | NIH | Vaccine

Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus

On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…

Read More Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel CoronavirusContinue

Mayo Clinic developed test to detect COVID-19 infection
Biotechnology | COVID-19 | Diagnostics | Infectious Disease

Mayo Clinic developed test to detect COVID-19 infection

On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…

Read More Mayo Clinic developed test to detect COVID-19 infectionContinue

Cocrystal Pharma announced plans to advance Coronavirus program
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Cocrystal Pharma announced plans to advance Coronavirus program

On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…

Read More Cocrystal Pharma announced plans to advance Coronavirus programContinue

Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection

On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…

Read More Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus InfectionContinue

Novavax advanced development of novel COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax advanced development of novel COVID-19 vaccine

On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…

Read More Novavax advanced development of novel COVID-19 vaccineContinue

Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
Biotechnology | Infectious Disease | NIH | Vaccine

Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study

On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…

Read More Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 studyContinue

Texas Biomed established team to study SARS-CoV-2, new coronavirus
COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Texas Biomed established team to study SARS-CoV-2, new coronavirus

On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…

Read More Texas Biomed established team to study SARS-CoV-2, new coronavirusContinue

FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
Biotechnology | Infectious Disease | Influenza | Vaccine

FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older

On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…

Read More FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and olderContinue

Page navigation

Previous PagePrevious 1 … 47 48 49 50 51 … 68 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search